Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1

Journal of Clinical Investigation
May 5, 2022
Cited by 64


Related Papers

No related papers found

Powered by citation graph analysis